# BАbykids Spray In Common Cold

> **NCT05819203** · NA · COMPLETED · sponsor: **Lallemand Pharma AG** · enrollment: 200 (actual)

## Conditions studied

- Common Cold
- Rhinitis Viral

## Interventions

- **DEVICE:** Healsea Babykids
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT05819203
- **Lead sponsor:** Lallemand Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-13
- **Primary completion:** 2023-05-16
- **Final completion:** 2023-05-16
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05819203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05819203, "BАbykids Spray In Common Cold". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05819203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*